The DOI matches its Crossref record; 151 of the 152 references it cites were found in a registry or an index.
The molecular logic of endocannabinoid signalling
Open accessOverview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Fatty acid amide hydrolase (FAAH) catalyzes the intracellular hydrolysis of the endocannabinoid anandamide.”
From Enhancement of anandamide-mediated endocannabinoid signaling corrects autism-related social impairment (2016) · cites this paper as [11]
In the citing paper
“This view is consistent with the presence of CB1 receptors on presynaptic terminals of both glutamatergic projection neurons and GABAergic interneurons.11”
From Enhancement of anandamide-mediated endocannabinoid signaling corrects autism-related social impairment (2016) · cites this paper as [11]
In the citing paper
“In contrast, CB 2 receptors are primarily expressed in immune cells, including myeloid, macrophage, microglia, lymphoid, and mast cells (Piomelli, 2003).”
From The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain (2018) · cites this paper as Piomelli, 2003
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Ledent, C. A., Valverde, O., Cossu, G., Petitet, F., Aubert, J.-F., Beslot, F., Böhme, G. A., Impérato, A., Pedrazzini, T., Roques, B. P., et al. (1999) · Science · doi:10.1126/science.283.5400.401 · Cited by 3,628
Drug Addiction, Dysregulation of Reward, and Allostasis
Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443 · cited 1×
“1 ), which led eventually to the pharmacological identification of cannabinoid-sensitive sites in the brai”
BackgroundIsolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,389
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
Flagged first, then by citations
1 of the 152 references couldn’t be matched to a known paper.
Research works printed but not linked: 4
- Rouyer, M. Sur les medicaments usuels des Egyptiens. Bull. Pharmacie 2, 25 (1810).
- O'Shaugnessy, W. B. On the Cannabis indica or Indian hemp. Pharmacol. J. Trans. 2, 594 (1843).
- Christison, R. in A Dispensatory, or Commentary on the Pharmacopoeias of Great Britain (and the United States) 971–974 (Lea and Blanchard, Philadelphia, 1848).
- Adams, R. Marihuana. Harvey Lect. 37, 168 (1941).
Cited by
Sorted by citations
Items 401–500 of 1,006
Formation of B and T cell subsets require the cannabinoid receptor CB2
Ziring, D., Wei, B., Velázquez, P., Schrage, M. I., Buckley, N. E., & Braun, J. G. (2006) · Immunogenetics · doi:10.1007/s00251-006-0138-x · Cited by 98
Dynamic Regulation of the Endocannabinoid System: Implications for Analgesia
Sagar, D. R., Gaw, A. G., Okine, B. N., Woodhams, S. G., Wong, A., Kendall, D. A., & Chapman, V. (2009) · Molecular Pain · doi:10.1186/1744-8069-5-59 · Cited by 99
Crespillo, A., Alonso, M., Vida, M., Pavón, F. J., Serrano, A., Rivera, P., Romero‐Zerbo, S., Fernández‐Llebrez, P., Martı́nez, A., Perez‐Valero, V., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01477.x · Cited by 97
Boon, M. R., Kooijman, S., van Dam, A. D., Pelgrom, L. R., Berbée, J. F. P., Visseren, C. A. R., Aggele, R. C., van den Hoek, A. M., Sips, H. C. M., Lombès, M., et al. (2014) · The FASEB Journal · doi:10.1096/fj.13-247643 · Cited by 102
Endocannabinoid system involvement in brain reward processes related to drug abuse
Solinas, M., Yaşar, S., & Goldberg, S. R. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.005 · Cited by 102
Sasso, O., Bertorelli, R., Bandiera, T., Scarpelli, R., Colombano, G., Armirotti, A., Moreno-Sanz, G., Reggiani, A., & Piomelli, D. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.02.012 · Cited by 96
Self-citationAlba, R. G., Barragán‐Iglesias, P., González‐Hernández, A., Valdez-Moráles, E. E., Granados‐Soto, V., Condés‐Lara, M., Rodríguez, M. G., & Marichal‐Cancino, B. A. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01496 · Cited by 95
Solinas, M., Panlilio, L. V., Tanda, G., Makriyannis, A., Matthews, S. A., & Goldberg, S. R. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300754 · Cited by 103
Marco, E. M., Echeverry‐Alzate, V., López‐Moreno, J. A., Giné, E., Peñasco, S., & Viveros, M. (2014) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000068 · Cited by 95
Ventral Tegmental Area Cannabinoid Type-1 Receptors Control Voluntary Exercise Performance
Dubreucq, S., Durand, A., Matias, I., Bénard, G., Richard, É. M., Gómez, E. S., Glangetas, C., Groc, L., Wadleigh, A., Massa, F., et al. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.10.025 · Cited by 95
Molecular architecture of endocannabinoid signaling at nociceptive synapses mediating analgesia
Nyilas, R., Gregg, L. C., Mackie, K., Watanabe, M., Zimmer, A., Hohmann, A. G., & Katona, I. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06751.x · Cited by 94
Endocannabinoid System: Emerging Role from Neurodevelopment to Neurodegeneration
Basavarajappa, B. S., Nixon, R. A., & Arancio, O. (2009) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955709787847921 · Cited by 98
Morozov, Y. M., Torii, M., & Rakic, P. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhp028 · Cited by 94
Endocannabinoid and ceramide levels are altered in patients with colorectal cancer
CHEN, L., CHEN, H., Li, Y., Li, L., Qiu, Y., & Ren, J. (2015) · Oncology Reports · doi:10.3892/or.2015.3973 · Cited by 94
Cannabinoid receptor stimulation is anti-inflammatory and improves memory in old rats
Marchalant, Y., Cerbai, F., Brothers, H. M., & Wenk, G. L. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.04.028 · Cited by 94
Marsicano, G., & Kuner, R. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3_10 · Cited by 103
Adenylyl Cyclase Type 5 Contributes to Corticostriatal Plasticity and Striatum-Dependent Learning
Kheirbek, M. A., Britt, J. P., Beeler, J. A., Ishikawa, Y., McGehee, D. S., & Zhuang, X. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3343-09.2009 · Cited by 93
Koethe, D., Gerth, C. W., Neatby, M. A., Haensel, A., Thies, M., Schneider, U., Emrich, H. M., Klosterkötter, J., Schultze-Lutter, F., & Leweke, F. M. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.07.023 · Cited by 93
Banister, S. D., & Connor, M. A. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_143 · Cited by 93
Cudaback, E., Marrs, W., Moeller, T., & Stella, N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008702 · Cited by 93
Compagnucci, C., Siena, S. D., Bustamante, M. B., Giacomo, D. D., Tommaso, M. D., Maccarrone, M., Grimaldi, P., & Sette, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054271 · Cited by 95
Fan, N., Yang, H., Zhang, J., & Chen, C. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06489.x · Cited by 92
Endocannabinoid-mediated synaptic plasticity and addiction-related behavior
Sidhpura, N., & Parsons, L. H. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.05.034 · Cited by 92
Marinelli, S., Pacioni, S., Bisogno, T., Marzo, V. D., Prince, D. A., Huguenard, J. R., & Bacci, A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0847-08.2008 · Cited by 92
Velasco, G., Carracedo, A., Blázquez, C., Lorente, M., Aguado, T., Haro, A., Sánchez, C., Galve‐Roperh, I., & Guzmán, M. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-0002-5 · Cited by 92
Rising stars: Modulation of brain functions by astroglial type‐1 cannabinoid receptors
Metna‐Laurent, M., & Marsicano, G. (2014) · Glia · doi:10.1002/glia.22773 · Cited by 100
Galve‐Roperh, I., Aguado, T., Rueda, D., Velasco, G., & Guzmán, M. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206777585139 · Cited by 92
The endocannabinoid system as a target for the treatment of cannabis dependence
Clapper, J. R., Mangieri, R. A., & Piomelli, D. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.018 · Cited by 94
Self-citationMarchalant, Y., Rosi, S., & Wenk, G. L. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.11.016 · Cited by 91
CB1 receptor antagonism: biological basis for metabolic effects
Marzo, V. D. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.09.001 · Cited by 90
Trezza, V., & Vanderschuren, L. J. M. J. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.141069 · Cited by 95
Guindon, J., & Beaulieu, P. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.12.002 · Cited by 90
King, A., Lodola, A., Carmi, C., Fu, J., Mor, M., & Piomelli, D. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00276.x · Cited by 91
Self-citationLooking for the role of cannabinoid receptor heteromers in striatal function
Ferré, S., Goldberg, S. R., Lluı́s, C., & Franco, R. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.076 · Cited by 89
Narushima, M., Uchigashima, M., Hashimoto, K., Watanabe, M., & Kano, M. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05119.x · Cited by 90
Gómez, O., Arévalo‐Martín, Á., García‐Ovejero, D., Ortega‐Gutiérrez, S., Cisneros, J. A., Almazán, G., Sanchez-Rodriguez, M. A., Molina‐Holgado, F., & Molina‐Holgado, E. (2010) · Glia · doi:10.1002/glia.21061 · Cited by 90
Hashimotodani, Y., Ohno‐Shosaku, T., Maejima, T., Fukami, K., & Kano, M. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.06.002 · Cited by 90
Cannabis, Cannabinoids and Schizophrenia: Integration of the Evidence
Cohen, M. A., Solowij, N., & Carr, V. J. (2008) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670801961156 · Cited by 90
Gobira, P. H., Vilela, L. R., Gonçalves, B. D. C., Santos, R. P. M., de Oliveira, A. C., Vieira, L. B., Aguiar, D. C., Crippa, J. A., & Moreira, F. A. (2015) · NeuroToxicology · doi:10.1016/j.neuro.2015.08.007 · Cited by 89
Zhang, Z., Wang, W., Zhong, P., Liu, S. J., Long, J. Z., Zhao, L., Gao, H., Cravatt, B. F., & Liu, Q. (2015) · Hippocampus · doi:10.1002/hipo.22344 · Cited by 89
Sang, N., Zhang, J., & Chen, C. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.105569 · Cited by 89
Astroglial CB1 cannabinoid receptors regulate leptin signaling in mouse brain astrocytes
Bosier, B., Bellocchio, L., Metna‐Laurent, M., Gómez, E. S., Matias, I., Hébert-Chatelain, É., Cannich, A., Maître, M., Lesté-Lasserre, T., Cardinal, P., et al. (2013) · Molecular Metabolism · doi:10.1016/j.molmet.2013.08.001 · Cited by 95
A review of nabilone in the treatment of chemotherapy-induced nausea and vomiting
Ware, M. A. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s1132 · Cited by 89
Cannabinoids and ceramide: Two lipids acting hand-by-hand
Velasco, G., Galve‐Roperh, I., Sánchez, C., Blázquez, C., Haro, A., & Guzmán, M. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.015 · Cited by 89
Common single nucleotide variants underlying drug addiction: more than a decade of research
Bühler, K., Giné, E., Echeverry‐Alzate, V., Calleja‐Conde, J., de Fonseca, F. R., & López‐Moreno, J. A. (2015) · Addiction Biology · doi:10.1111/adb.12204 · Cited by 96
Nomura, D. K., & Casida, J. E. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf101747r · Cited by 91
Bidirectional regulation of novelty-induced behavioral inhibition by the endocannabinoid system
Lafenêtre, P., Chaouloff, F., & Marsicano, G. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.07.014 · Cited by 88
The Endocannabinoid System in Peripheral Lymphocytes as a Mirror of Neuroinflammatory Diseases
Centonze, D., Battistini, L., & Maccarrone, M. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208785740018 · Cited by 86
Cannabis and neurodevelopment: implications for psychiatric disorders
Sundram, S. (2006) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.762 · Cited by 86
The CB1 Receptor as the Cornerstone of Exostasis
Piazza, P. V., Cota, D., & Marsicano, G. (2017) · Neuron · doi:10.1016/j.neuron.2017.02.002 · Cited by 100
Cannabis: A Treasure Trove or Pandora's Box?
Solymosi, K., & Köfalvi, A. (2016) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557516666161004162133 · Cited by 93
Monoacylglycerol lipase regulates 2-arachidonoylglycerol action and arachidonic acid levels
Nomura, D. K., Hudak, C. S. S., Ward, A. M., Burston, J. J., Issa, R. S., Fisher, K. J., Abood, M. E., Wiley, J. L., Lichtman, A. H., & Casida, J. E. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.08.007 · Cited by 93
Epigenetic Regulation of Fatty Acid Amide Hydrolase in Alzheimer Disease
D’Addario, C., Francesco, A. D., Arosio, B., Gussago, C., Dell’Osso, B. M., Bari, M., Galimberti, D., Scarpini, E. A., Altamura, A. C., Mari, D., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039186 · Cited by 87
Kreutz, S., Koch, M., Böttger, C., Ghadban, C., Korf, H., & Dehghani, F. (2008) · Glia · doi:10.1002/glia.20756 · Cited by 87
Lateral regulation of synaptic transmission by astrocytes.
Covelo, A., & Araque, A. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.02.036 · Cited by 77
Effects of Δ9-Tetrahydrocannabinol on Human Working Memory Function
Bossong, M. G., Jansma, J. M., van Hell, H. H., Jager, G., Oudman, E., Saliasi, E., Kahn, R. S., & Ramsey, N. F. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.01.008 · Cited by 89
Panagis, G., Mackey, B., & Vlachou, S. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00092 · Cited by 87
Endocannabinoid signaling in astrocytes
Eraso‐Pichot, A., Pouvreau, S., Oliveira-Pinto, A., Gómez-Sotres, P., Skupio, U., & Marsicano, G. (2022) · Glia · doi:10.1002/glia.24246 · Cited by 89
Núñez, E., Benito, C., Tolón, R. M., Hillard, C. J., Griffin, W. S. T., & Romero, J. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2007.10.029 · Cited by 86
Nicotinic α 7 Receptors as a New Target for Treatment of Cannabis Abuse
Solinas, M., Scherma, M., Fattore, L., Stroik, J., Wertheim, C. E., Tanda, G., Fratta, W., & Goldberg, S. R. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0027-07.2007 · Cited by 90
Xie, S., Borazjani, A., Hatfield, M. J., Edwards, C. C., Potter, P. M., & Ross, M. K. (2010) · Chemical Research in Toxicology · doi:10.1021/tx1002194 · Cited by 87
Endocannabinoids in brain plasticity: Cortical maturation, HPA axis function and behavior
Dow-Edwards, D. L., & Silva, L. (2016) · Brain Research · doi:10.1016/j.brainres.2016.08.037 · Cited by 92
López-Rodríguez, A. B., Siopi, E., Finn, D. P., Marchand‐Leroux, C., García‐Segura, L. M., Jafarian-Tehrani, M., & Viveros, M. (2013) · Cerebral Cortex · doi:10.1093/cercor/bht202 · Cited by 85
Trezza, V., & Campolongo, P. (2013) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2013.00100 · Cited by 87
Control of glutamate release by complexes of adenosine and cannabinoid receptors
Köfalvi, A., Moreno, E., Cordomí, A., Cai, N.-S., Fernández‐Dueñas, V., Ferreira, S. G., Guixà-González, R., Sánchez‐Soto, M., Yano, H., Casadó-Anguera, V., et al. (2020) · BMC Biology · doi:10.1186/s12915-020-0739-0 · Cited by 84
Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?
Rossi, F., Tortora, C., Argenziano, M., Paola, A. D., & Punzo, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113809 · Cited by 83
Choi, K. H., Le, T., McGuire, J. L., Xing, G., Zhang, L., Li, H., Parker, C. C., Johnson, L. R., & Ursano, R. J. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.03.021 · Cited by 84
Ade, K. K., & Lovinger, D. M. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.2916-06.2007 · Cited by 83
Jiang, S., Fu, Y., Williams, J. S., Wood, J. T., Pandarinathan, L., Avraham, S., Makriyannis, A., Avraham, S., & Avraham, H. K. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000641 · Cited by 84
Lodola, A., Mor, M., Żurek, J., Tarzia, G., Piomelli, D., Harvey, J. N., & Mulholland, A. J. (2006) · Biophysical Journal · doi:10.1529/biophysj.106.098434 · Cited by 84
Self-citationChapter 5 The Endocannabinoid System as A Target for Novel Anxiolytic and Antidepressant Drugs
Gaetani, S., Dipasquale, P., Romano, A., Righetti, L., Cassano, T., Piomelli, D., & Cuomo, V. (2009) · International Review of Neurobiology · doi:10.1016/s0074-7742(09)85005-8 · Cited by 83
Self-citationOxytocin functions as a spatiotemporal filter for excitatory synaptic inputs to VTA dopamine neurons
Xiao, L., Priest, M. F., & Kozorovitskiy, Y. (2018) · eLife · doi:10.7554/elife.33892 · Cited by 83
“We used a version of Scanimage to control scanning parameters and image acquisition (Kozorovitskiy et al., 2015; Pologruto et al., 2003).”
MethodΔ 9 -Tetrahydrocannabinol and Cannabidiol Differentially Regulate Intraocular Pressure
Miller, S., Daily, L., Leishman, E., Bradshaw, H. B., & Straiker, A. J. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-24838 · Cited by 84
Alger, B. E. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2011.220855 · Cited by 82
Rossi, S., De Chiara, V., Musella, A., Sacchetti, L., Cantarella, C., Castelli, M., Cavasinni, F., Motta, C., Studer, V., Bernardi, G., et al. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.064196 · Cited by 82
Targeted lipidomics: Discovery of new fatty acyl amides
Tan, B., Bradshaw, H. B., Rimmerman, N., Srinivasan, H., Yu, Y. W., Krey, J. F., Monn, M. F., Chen, J. S.-C., Hu, S. S., Pickens, S. R., et al. (2006) · The AAPS Journal · doi:10.1208/aapsj080354 · Cited by 82
Current evidence linking diet to gut microbiota and brain development and function
Ceppa, F., Mancini, A., & Tuohy, K. M. (2018) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2018.1462309 · Cited by 83
Endocannabinoid System in Hepatic Glucose Metabolism, Fatty Liver Disease, and Cirrhosis
Bazwinsky‐Wutschke, I., Zipprich, A., & Dehghani, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102516 · Cited by 85
Favia, A. D., Habrant, D., Scarpelli, R., Migliore, M., Albani, C., Bertozzi, S. M., Dionisi, M., Tarozzo, G., Piomelli, D., Cavalli, A., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3011146 · Cited by 82
Self-citationNeural Plasticity in Multiple Sclerosis: The Functional and Molecular Background
Ksiazek-Winiarek, D. J., Szpakowski, P., & Glabinski, A. R. (2015) · Neural Plasticity · doi:10.1155/2015/307175 · Cited by 88
Mikasová, L., Groc, L., Choquet, D., & Manzoni, O. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805959105 · Cited by 82
Navarria, A., Tamburella, A., Iannotti, F. A., Micale, V., Camillieri, G., Gozzo, L., Verde, R., Imperatore, R., Leggio, G. M., Drago, F., et al. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.04.014 · Cited by 82
The Role of Endocannabinoid Signaling in Motor Control
Manira, A. E., & Kyriakatos, A. (2010) · Physiology · doi:10.1152/physiol.00007.2010 · Cited by 92
Cota, D. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01673.x · Cited by 82
Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain
Davis, M. P. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.1.85 · Cited by 82
Hofmann, M. E., & Frazier, C. J. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.11.047 · Cited by 83
Endocannabinoid signaling in the gut mediates preference for dietary unsaturated fats
DiPatrizio, N. V., Joslin, A., Jung, K., & Piomelli, D. (2013) · The FASEB Journal · doi:10.1096/fj.13-227587 · Cited by 81
Self-citationMassi, L., Elezgarai, I., Puente, N., Reguero, L., Grandes, P., Manzoni, O. J., & Georges, F. E. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.2291-08.2008 · Cited by 82
Fear relief—toward a new conceptual frame work and what endocannabinoids gotta do with it
Riebe, C. J. N., Pamplona, F. A., Kamprath, K., & Wotjak, C. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.11.057 · Cited by 84
Endocannabinoid Regulation of Acute and Protracted Nicotine Withdrawal: Effect of FAAH Inhibition
Cippitelli, A., Astarita, G., Duranti, A., Caprioli, G., Ubaldi, M., Stopponi, S., Kallupi, M., Sagratini, G., de Fonseca, F. R., Piomelli, D., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028142 · Cited by 81
Self-citationDynamic changes of anandamide in the cerebrospinal fluid of Parkinson's disease patients
Pisani, V., Moschella, V., Bari, M., Fezza, F., Galati, S., Bernardi, G., Stanzione, P., Pisani, A., & Maccarrone, M. (2010) · Movement Disorders · doi:10.1002/mds.23014 · Cited by 84
Iravani, M. M., & Jenner, P. G. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0698-2 · Cited by 82
Lazarevic, V., Yang, Y., Flais, I., & Svenningsson, P. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01246-3 · Cited by 81
The Phylogenetic Distribution and Evolutionary Origins of Endocannabinoid Signalling
Elphick, M. R., & Egertová, M. (2005) · Springer eBooks · doi:10.1007/3-540-26573-2_9 · Cited by 80
Steiner, M. A., Marsicano, G., Wotjak, C. T., & Lutz, B. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.06.004 · Cited by 80
Rossi, S., Furlan, R., Chiara, V. D., Muzio, L., Musella, A., Motta, C., Studer, V., Cavasinni, F., Bernardi, G., Martino, G., et al. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.03.017 · Cited by 78
The cannabinoid CB 1 receptor and the endocannabinoid anandamide: possible antidepressant targets
Bambico, F. R., & Gobbi, G. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.11.1347 · Cited by 80
Cannabinoids enhance susceptibility of immature brain to ethanol neurotoxicity
Hansen, H. H., Krutz, B., Sifringer, M., Stefovska, V. G., Bittigau, P., Pragst, F., Marsicano, G., Lutz, B., & Ikonomidou, C. (2007) · Annals of Neurology · doi:10.1002/ana.21287 · Cited by 79
Morrison, P. D., Nottage, J. F., Stone, J. M., Bhattacharyya, S., Tunstall, N., Brenneisen, R., Holt, D., Wilson, D., Sumich, A. L., McGuire, P. K., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.222 · Cited by 83
Role of the endocannabinoid system in the regulation of intestinal homeostasis
Cuddihey, H., MacNaughton, W. K., & Sharkey, K. A. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.05.015 · Cited by 79
Metadata
- Authors
- Piomelli, D.
- Affiliations
- University of California, Irvine (US)
- Corresponding author
- Piomelli, Daniele
- ORCID
- Piomelli, Daniele
- Venue
- Nature Reviews Neuroscience
- Published
- 2003-11
- Volume
- 4
- Issue
- 11
- Pages
- 873-884
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2080649553
- Cited by
- 1,957
- References
- 152
- Citations by year
- 2026: 39 · 2025: 42 · 2024: 43 · 2023: 50 · 2022: 76 · 2021: 77 · 2020: 81 · 2019: 71 · 2018: 67 · 2017: 79 · 2016: 81 · 2015: 100 · 2014: 100 · 2013: 95 · 2012: 108
- FWCI
- 9.35
- Type
- journal article
- Language
- en
- Open access
- green
- escholarship.org
- Licence
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- National Alliance for Research on Schizophrenia and Depression
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- endocannabinoids, endocannabinoid signaling, CB1 receptor, delta-9-tetrahydrocannabinol, cannabinoid receptors, neurotransmitter release, ion channel modulation, synaptic plasticity, axon terminals
- MeSH terms
- Animals, Cannabis, gamma-Aminobutyric Acid, Hallucinogens, Humans, Synaptic Transmission, Dronabinol, Signal Transduction, Neurotransmitter Agents, Glutamic Acid, Receptor, Cannabinoid, CB1, Cannabinoid Receptor Modulators, Endocannabinoids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review